https://doi.org/10.1016/j.ebiom.2020.102647
S
Simon Fietz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
280
Citations
7
h-index
6
i10-index
Simon Fietz is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 7, co-authored 10 publications.
ORCID: 0000-0003-3745-9125Papers by this author
worksComprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma
2020 · EBioMedicine · 71 citations
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma
2020 · EBioMedicine · 65 citations
https://doi.org/10.1016/j.ebiom.2020.102962
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
2020 · Cancer Immunology Immunotherapy · 32 citations
https://doi.org/10.1007/s00262-020-02777-4
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy
2022 · Clinical Epigenetics · 26 citations
https://doi.org/10.1186/s13148-022-01270-2
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
2023 · Clinical Epigenetics · 23 citations
https://doi.org/10.1186/s13148-023-01525-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat